Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses

被引:4
|
作者
Haveri, Anu [1 ]
Ikonen, Niina [1 ]
Kantele, Anu [2 ,3 ]
Anttila, Veli-Jukka [2 ,3 ]
Ruotsalainen, Eeva [2 ,3 ]
Savolainen-Kopra, Carita [1 ]
Julkunen, Ilkka [1 ,4 ,5 ]
机构
[1] Natl Inst Hlth & Welf THL, Dept Hlth Secur, Expert Microbiol Unit, POB 30, Helsinki 00271, Finland
[2] Univ Helsinki, Inflammat Ctr, Div Infect Dis, POB 348, Hus Helsinki 00029, Finland
[3] Helsinki Univ Hosp, POB 348, Hus Helsinki 00029, Finland
[4] Univ Turku, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
[5] Turku Univ Hosp, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
关键词
Antibodies; Microneutralization test; Humoral immunity; Influenza A; Pandemic; Vaccine; HEMAGGLUTINATION INHIBITION; H1N1; 2009; ANTIGENIC STRUCTURE; PHASE-III; IMMUNOGENICITY; SAFETY; VACCINATION; CANDIDATE; CHILDREN; A(H3N2);
D O I
10.1016/j.vaccine.2019.03.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza A(H1N1)pdm09 viruses have been circulating throughout the world since the 2009 pandemic. A/California/07/2009 (H1N1) virus was included in seasonal influenza vaccines for seven years altogether, providing a great opportunity to analyse vaccine-induced immunity in relation to the postpandemic evolution of the A(H1N1)pdm09 virus. Serum antibodies against various epidemic strains of influenza A (H1N1)pdm09 viruses were measured among health care workers (HCWs) by haemagglutination inhibition and microneutralization tests before and after 2010 and 2012 seasonal influenza vaccinations. We detected high responses of vaccine-induced neutralizing antibodies to six distinct genetic groups. Our results indicate antigenic similarity between vaccine and circulating A(H1N1)pdm09 strains, and substantial vaccine-induced immunity against circulating epidemic viruses. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:2731 / 2740
页数:10
相关论文
共 50 条
  • [21] A(H1N1) pdm09 influenza infection: vaccine inefficiency
    Friedman, Nehemya
    Drori, Yaron
    Pando, Rakefet
    Glatman-Freedman, Aharona
    Sefty, Hanna
    Bassal, Ravit
    Stein, Yaniv
    Shohat, Tamy
    Mendelson, Ella
    Hindiyeh, Musa
    Mandelboim, Michal
    ONCOTARGET, 2017, 8 (20) : 32856 - 32863
  • [22] Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
    Roy-Ghanta, Sumita
    Van der Most, Robbert
    Li, Ping
    Vaughn, David W.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (09): : 1419 - 1430
  • [23] Influenza A(H1N1)pdm09 during air travel
    Neatherlin, John
    Cramer, Elaine H.
    Dubray, Christine
    Marienau, Karen J.
    Russell, Michelle
    Sun, Hong
    Whaley, Melissa
    Hancock, Kathy
    Duong, Krista K.
    Kirking, Hannah L.
    Schembri, Christopher
    Katz, Jacqueline M.
    Cohen, Nicole J.
    Fishbein, Daniel B.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2013, 11 (02) : 110 - 118
  • [24] Structural Stability of Influenza A(H1N1)pdm09 Virus
    Yang, Hua
    Chang, Jessie C.
    Guo, Zhu
    Carney, Paul J.
    Shore, David A.
    Donis, Ruben O.
    Cox, Nancy J.
    Villanueva, Julie M.
    Klimov, Alexander I.
    Stevens, James
    JOURNAL OF VIROLOGY, 2014, 88 (09) : 4828 - 4838
  • [25] Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
    Liu, Mi
    Liu, Jingze
    Song, Wenjun
    Peng, Yousong
    Ding, Xiao
    Deng, Lizong
    Jiang, Taijiao
    VIROLOGICA SINICA, 2023, 38 (04) : 541 - 548
  • [26] Seroprevalence of Influenza A(H1N1) pdm09 Virus Antibody, England, 2010 and 2011
    Hoschler, Katja
    Thompson, Catherine
    Andrews, Nick
    Galiano, Monica
    Pebody, Richard
    Ellis, Joanna
    Stanford, Elaine
    Baguelin, Marc
    Miller, Elizabeth
    Zambon, Maria
    EMERGING INFECTIOUS DISEASES, 2012, 18 (11) : 1894 - 1897
  • [27] Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09
    Huang, Yu
    Zhu, Wei
    Zeng, Xing
    Li, Shasha
    Li, Xiaoyan
    Lu, Chuanjian
    ARCHIVES OF VIROLOGY, 2013, 158 (11) : 2267 - 2272
  • [28] Swine influenza in Norway: a distinct lineage of influenza A(H1N1)pdm09 virus
    Forberg, Hilde
    Hauge, Anna G.
    Gjerset, Britt
    Hungnes, Olav
    Kilander, Anette
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 : 21 - 26
  • [29] Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children
    Kotloff, Karen L.
    Halasa, Natasha B.
    Harrison, Christopher J.
    Englund, Janet A.
    Walter, Emmanuel B.
    King, James C.
    Creech, C. Buddy
    Healy, Sara A.
    Dolor, Rowena J.
    Stephens, Ina
    Edwards, Kathryn M.
    Noah, Diana L.
    Hill, Heather
    Wolff, Mark
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (08) : 865 - 871
  • [30] Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
    Friel, Damien
    Co, Mary
    Ollinger, Thierry
    Salaun, Bruno
    Schuind, Anne
    Li, Ping
    Walravens, Karl
    Ennis, Francis A.
    Vaughn, David W.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (01) : 110 - 120